• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Brainstorm Health Daily: June 13, 2017
Health
Brainstorm Health Daily: June 13, 2017
By Clifton Leaf and Sy MukherjeeJune 13, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
Health
This Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat
By Sy MukherjeeJune 12, 2017
Senate Lawmakers Speak To The Press After Their Weekly Policy Luncheons
Health
The Senate Is Finalizing a Health Care Bill But You’re Not Allowed to See It
By Sy MukherjeeJune 12, 2017
Brainstorm Health Daily: June 12, 2017
Health
Brainstorm Health Daily: June 12, 2017
By Clifton Leaf and Sy MukherjeeJune 12, 2017
Birth Control
Health
This Birth Control Is Being Recalled After Pills Were Packaged Out of Order
By Sy MukherjeeJune 9, 2017
Brainstorm Health Daily: June 9, 2017
Health
Brainstorm Health Daily: June 9, 2017
By Clifton Leaf and Sy MukherjeeJune 9, 2017
Hands Presenting Heart
Health
America’s Heart Health Divide Is Linked to How Much Money You Make
By Sy MukherjeeJune 8, 2017
Brainstorm Health Daily: June 8, 2017
Health
Brainstorm Health Daily: June 8, 2017
By Clifton Leaf and Sy MukherjeeJune 8, 2017
New York Attorney General Eric T. Schneiderman Announces Large Heroin Bust
Health
Why Fentanyl Terrifies the DEA and Medical Experts Even More Than Other Opioids
By Sy MukherjeeJune 7, 2017
Brainstorm Health Daily: June 7, 2017
Health
Brainstorm Health Daily: June 7, 2017
By Clifton Leaf and Sy MukherjeeJune 7, 2017
Forbes Under 30 Summit
Health
This 31-Year-Old Just Launched His 5th Biotech Company With a Boost From Merck
By Sy MukherjeeJune 6, 2017
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health
3 Key Takeaways from the World’s Biggest Cancer Conference
By Sy MukherjeeJune 6, 2017
Brainstorm Health Daily: June 6, 2017
Health
Brainstorm Health Daily: June 6, 2017
By Clifton Leaf and Sy MukherjeeJune 6, 2017
Johnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%
Health
Johnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%
By Sy MukherjeeJune 5, 2017
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health
Roche Loses Billions in Value After Pricey Breast Cancer Drug Combo Disappoints
By Sy MukherjeeJune 5, 2017
1...
  • 86
  • 87
  • 88
  • 89
  • 90
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.